Pleural effusion during bromocriptine exposure in two patients with pre-existing asbestos pleural plaques: a relationship?

被引:5
作者
Knoop, C
Mairesse, M
Lenclud, C
Gevenois, PA
De Vuyst, P
机构
[1] Erasme Hosp, Dept Chest Med, B-1070 Brussels, Belgium
[2] Erasme Hosp, Dept Radiol, Brussels, Belgium
[3] Clin Univ St Luc, Dept Chest Med, Bouge, Belgium
关键词
benign asbestos pleural effusion; bromocriptine; drug-induced pleural effusion; ergoline; ergot-derived dopamine agonists; Parkinson's disease;
D O I
10.1183/09031936.97.10122898
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Two patients with pleural plaques developed pleural effusion and subsequent diffuse pleural fibrosis 50 and 39 yrs after their first exposure to asbestos, The diagnosis of benign asbestos pleural effusion was suggested, but the work-up finally suggested bromocriptine-induced pleural disease in both patients. These two cases illustrate that drug-induced pleural effusion is an important differential diagnosis of benign asbestos pleural effusion, It is, moreover, possible that pre-existing asbestos pleural lesions, or even asbestos exposure, increases the risk of developing bromocriptine-induced pleural disease.
引用
收藏
页码:2898 / 2901
页数:4
相关论文
共 15 条
[11]  
LILIS R, 1988, BRIT J IND MED, V45, P443
[12]   PLEUROPULMONARY DISEASE DURING BROMOCRIPTINE TREATMENT OF PARKINSON DISEASE [J].
MCELVANEY, NG ;
WILCOX, PG ;
CHURG, A ;
FLEETHAM, JA .
ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (10) :2231-2236
[13]   Pleuropulmonary changes induced by ergoline drugs [J].
Pfitzenmeyer, P ;
Foucher, P ;
Dennewald, G ;
Chevalon, B ;
Debieuvre, D ;
Bensa, P ;
Piard, F ;
Camus, P .
EUROPEAN RESPIRATORY JOURNAL, 1996, 9 (05) :1013-1019
[14]  
RINNE UK, 1981, LANCET, V1, P44
[15]   BROMOCRIPTINE INDUCED PLEUROPULMONARY FIBROSIS [J].
WIGGINS, J ;
SKINNER, C .
THORAX, 1986, 41 (04) :328-330